OpenRegistry

THE ANTI-AGEING TREATMENT CENTRE LIMITED

Dissolved
08260129·incorporated 2012-10-19

THE ANTI-AGEING TREATMENT CENTRE LIMITED is a dissolved UK private limited company, incorporated on 19 October 2012 at Companies House (number 08260129; OpenRegistry canonical ID GB-08260129-the-anti-ageing-treatment-centre-limited). Sophymarine's OpenRegistry classifies it under SIC 86900 (Other human health activities), one of 83,037 active UK entities in that code and one of 6,593 active companies registered in Leamington Spa, Warwickshire (postcode CV31). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Dissolved
Type
Private Limited Company
Incorporated
2012-10-19
Registered Address
HIGHDOWN HOUSE, 11 HIGHDOWN ROAD, LEAMINGTON SPA, WARWICKSHIRE, CV31 1XT, ENGLAND
SIC
86900 — Other human health activities
Country of origin
United Kingdom

Accounts

Last filed accounts made up to 2024-03-31. Next accounts due 2025-12-31. Financial year-end: 31/03. Filing class: TOTAL EXEMPTION FULL.

Confirmation statement

Last confirmation statement made up to 2025-06-01. Next confirmation statement due 2026-06-15.

Persons with significant control

THE ANTI-AGEING TREATMENT CENTRE LIMITED has 1 person with significant control on file:

  • The Maple Group Limited (England And Wales reg. 10677816). Notified 2019-04-06.
    • Owns 75% or more of shares
    • Holds 75% or more of voting rights
    • Has the right to appoint and remove directors

3 historical PSC records have ceased:

  • Mrs Rozmina Pabani born 1967 resident in England, Canadian national. Notified 2016-04-06. Ceased 2017-11-01.
    • Owns 75% or more of shares
    • Holds 75% or more of voting rights
  • The Maple Group Limited (England reg. 10677816). Notified 2017-11-01. Ceased 2019-04-06.
    • Owns 75% or more of shares
    • Holds 75% or more of voting rights
    • Has the right to appoint and remove directors
  • Mr Mahebub Noorali Karim born 1951 resident in England, British national. Notified 2019-04-06. Ceased 2019-04-06.
    • Owns 50–75% of shares
    • Holds 50–75% of voting rights
    • Has the right to appoint and remove directors